Last updated on 15 May 2023
Owner Info
Allogene Therapeutics, Inc.
210 E. Grand Avenue
South San Francisco CA 94080, UNITED STATES OF AMERICA
Serial Number
2004344 filed on 14 Mar 2019
Correspondent
Jason S. Howell Perkins Coie LLP
1201 Third Avenue, Suite 4900,
Seattle WA 98101,
UNITED STATES OF AMERICA
2004344
14 Mar 2019
NA
WORD
18 Sept 2018
US
Status Date | Action Taken |
---|---|
15th May 2023 | Status change to Voided |
9th Oct 2019 | International Registration in Australia Protected correspondence sent |
8th Oct 2019 | IP Right Registration Published |
8th Oct 2019 | Status change to Registered/Protected |
30th Jul 2019 | Application Accepted correspondence sent |
29th Jul 2019 | IP Right Acceptance Published |
29th Jul 2019 | IP Right has been Examined |
29th Jul 2019 | Status change to Accepted |
18th Apr 2019 | Awaiting examination |
18th Apr 2019 | Examination expedited |